Kari Laine

3.9k total citations
78 papers, 2.9k citations indexed

About

Kari Laine is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Anesthesiology and Pain Medicine. According to data from OpenAlex, Kari Laine has authored 78 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pharmacology, 19 papers in Public Health, Environmental and Occupational Health and 18 papers in Anesthesiology and Pain Medicine. Recurrent topics in Kari Laine's work include Pharmacogenetics and Drug Metabolism (28 papers), Pain Management and Opioid Use (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Kari Laine is often cited by papers focused on Pharmacogenetics and Drug Metabolism (28 papers), Pain Management and Opioid Use (13 papers) and Pharmacological Effects and Toxicity Studies (12 papers). Kari Laine collaborates with scholars based in Finland, Sweden and Germany. Kari Laine's co-authors include Terho Heikkinen, Pertti J. Neuvonen, Ulla Ekblad, Klaus T. Olkkola, Teijo I. Saari, Nora Hagelberg, Pentti Kero, Mikko Neuvonen, Leif Bertilsson and Gunnel Tybring and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Anesthesiology and Psychopharmacology.

In The Last Decade

Kari Laine

78 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Laine Finland 33 823 749 728 406 402 78 2.9k
John van den Anker United States 31 485 0.6× 1.8k 2.4× 666 0.9× 608 1.5× 412 1.0× 172 3.8k
Raymond Miller United States 27 530 0.6× 608 0.8× 193 0.3× 285 0.7× 128 0.3× 70 2.8k
Simon H. L. Thomas United Kingdom 33 330 0.4× 304 0.4× 702 1.0× 452 1.1× 149 0.4× 134 3.8k
Jan de Hoon Belgium 35 243 0.3× 1.0k 1.4× 293 0.4× 657 1.6× 443 1.1× 180 3.6k
Evan J. Begg New Zealand 40 832 1.0× 816 1.1× 549 0.8× 1.3k 3.1× 79 0.2× 145 4.5k
Jouni Ahonen Finland 27 149 0.2× 496 0.7× 467 0.6× 183 0.5× 657 1.6× 87 2.6k
Catherine M.T. Sherwin United States 38 437 0.5× 1.1k 1.5× 291 0.4× 1.1k 2.7× 128 0.3× 208 3.8k
Kathi Hall United States 19 661 0.8× 598 0.8× 163 0.2× 957 2.4× 297 0.7× 30 4.6k
Jacob V. Aranda United States 42 396 0.5× 2.7k 3.6× 268 0.4× 716 1.8× 236 0.6× 221 6.1k
David Foster Australia 31 421 0.5× 525 0.7× 438 0.6× 333 0.8× 507 1.3× 109 4.0k

Countries citing papers authored by Kari Laine

Since Specialization
Citations

This map shows the geographic impact of Kari Laine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Laine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Laine more than expected).

Fields of papers citing papers by Kari Laine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Laine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Laine. The network helps show where Kari Laine may publish in the future.

Co-authorship network of co-authors of Kari Laine

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Laine. A scholar is included among the top collaborators of Kari Laine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Laine. Kari Laine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Böttiger, Ylva, et al.. (2017). Development and pilot testing of PHARAO—a decision support system for pharmacological risk assessment in the elderly. European Journal of Clinical Pharmacology. 74(3). 365–371. 22 indexed citations
2.
Hagelberg, Nora, Kristiina Kuusniemi, Janne T. Backman, et al.. (2016). Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction. European Journal of Clinical Pharmacology. 72(11). 1363–1371. 13 indexed citations
3.
Grönlund, Juha, Teijo I. Saari, Nora Hagelberg, et al.. (2010). Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. British Journal of Clinical Pharmacology. 70(1). 78–87. 61 indexed citations
4.
Grönlund, Juha, Teijo I. Saari, Nora Hagelberg, et al.. (2010). Effect of Inhibition of Cytochrome P450 Enzymes 2D6 and 3A4 on the Pharmacokinetics of Intravenous Oxycodone. Clinical Drug Investigation. 31(3). 143–153. 37 indexed citations
5.
Sailas, Liisa, et al.. (2010). NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer. Cancer Chemotherapy and Pharmacology. 67(6). 1353–1362. 10 indexed citations
6.
Hagelberg, Nora, Teijo I. Saari, Mikko Neuvonen, et al.. (2010). St John's wort greatly reduces the concentrations of oral oxycodone. European Journal of Pain. 14(8). 854–859. 52 indexed citations
7.
Vahlberg, Tero, et al.. (2009). The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Annals of Medicine. 41(8). 619–628. 54 indexed citations
8.
Heikkinen, Terho, et al.. (2009). The effect of probenecid and MK-571 on the feto-maternal transfer of saquinavir in dually perfused human term placenta. European Journal of Pharmaceutical Sciences. 37(5). 588–592. 13 indexed citations
9.
Tertti, Kristiina, Ulla Ekblad, Terho Heikkinen, et al.. (2009). The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta. European Journal of Pharmaceutical Sciences. 39(1-3). 76–81. 25 indexed citations
10.
Olkkola, Klaus T., et al.. (2008). Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. European Journal of Clinical Pharmacology. 65(1). 89–95. 12 indexed citations
11.
Turpeinen, Miia, et al.. (2008). Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone. The Journal of Steroid Biochemistry and Molecular Biology. 110(1-2). 56–66. 35 indexed citations
12.
Rane, Anders, et al.. (2007). Genetic polymorphism of cytochrome P450s and P‐glycoprotein in the Finnish population. Fundamental and Clinical Pharmacology. 21(4). 379–386. 27 indexed citations
13.
14.
Turpeinen, Miia, Niina Koivuviita, Ari Tolonen, et al.. (2007). Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites. British Journal of Clinical Pharmacology. 64(2). 165–173. 34 indexed citations
15.
Olkkola, Klaus T., Kari Leino, Stefan Lundgren, et al.. (2007). Effect of voriconazole on the pharmacokinetics of diclofenac. Fundamental and Clinical Pharmacology. 21(6). 651–656. 18 indexed citations
16.
Saari, Teijo I., Kari Laine, Mikko Neuvonen, Pertti J. Neuvonen, & Klaus T. Olkkola. (2007). Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. European Journal of Clinical Pharmacology. 64(1). 25–30. 59 indexed citations
17.
Paija, Outi, Kari Laine, Mika Leinonen, et al.. (2005). Entacapone Increases Levodopa Exposure and Reduces Plasma Levodopa Variability When Used With Sinemet CR. Clinical Neuropharmacology. 28(3). 115–119. 22 indexed citations
18.
Aaltonen, Riikka, Terho Heikkinen, Kristo Hakala, Kari Laine, & A. Alanen. (2005). Transfer of Proinflammatory Cytokines Across Term Placenta. Obstetrics and Gynecology. 106(4). 802–807. 172 indexed citations
19.
Laine, Kari, et al.. (2004). Severe Adverse Effects in a Newborn with Two Defective CYP2D6 Alleles After Exposure to Paroxetine During Late Pregnancy. Therapeutic Drug Monitoring. 26(6). 685–687. 28 indexed citations
20.
Tybring, Gunnel, et al.. (2003). The effect of ethinyloestradiol and levonorgestrel on the CYP2C19‐mediated metabolism of omeprazole in healthy female subjects. British Journal of Clinical Pharmacology. 56(2). 232–237. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John van den Anker Breakdown of academic impact, for papers by Raymond Miller Breakdown of academic impact, for papers by Simon H. L. Thomas Breakdown of academic impact, for papers by Jan de Hoon Breakdown of academic impact, for papers by Evan J. Begg Breakdown of academic impact, for papers by Jouni Ahonen Breakdown of academic impact, for papers by Catherine M.T. Sherwin Breakdown of academic impact, for papers by Kathi Hall Breakdown of academic impact, for papers by Jacob V. Aranda Breakdown of academic impact, for papers by David Foster
Rankless by CCL
2026